Bloomberg’s acclaimed investigative series, Bad Medicine, has been awarded the Gerald Loeb Award in Audio, one of the highest honors in business journalism. The series, part of The Business of Bad Medicine column, explores how porous regulations and manufacturing shortcuts have allowed dangerous drugs to circulate globally—often with devastating consequences.

Valisure was featured in several key stories and recognized for its role in independently testing medications and identifying serious quality concerns that would otherwise go unnoticed.

We are proud to have worked with Bloomberg journalists Zachary Mider, Anna Edney, and Riley Griffin, whose reporting has been instrumental in driving awareness and accountability in pharmaceutical safety.

Highlighted Coverage Featuring Valisure:

• Indian-Made Cold Syrup Sent to Iraq Contains Poison, Test Shows (July 28, 2023)
• WHO Warns About Tainted Indian-Made Cold Medicine That’s Sold in Iraq (Aug. 7, 2023)
• The Pentagon Wants to Root Out Shoddy Drugs. The FDA Is In Its Way. (Dec. 4, 2023)
• US Military at Risk From Reliance on Cheap Foreign Drugs, Senators Say (March 19, 2024)

Key Stats:

• $50 billion – Estimated size of India’s pharmaceutical industry, the world’s largest producer of generics
• 900 – Number of drug recalls issued by the FDA in 2022, triple the number from four years prior

Valisure congratulates the Bloomberg team on this well-deserved honor and remains committed to advancing transparency and accountability in drug safety worldwide.

Read the full series via Bloomberg here.

‍

Bloomberg’s acclaimed investigative series, Bad Medicine, has been awarded the Gerald Loeb Award in Audio, one of the highest honors in business journalism. The series, part of The Business of Bad Medicine column, explores how porous regulations and manufacturing shortcuts have allowed dangerous drugs to circulate globally—often with devastating consequences.

Valisure was featured in several key stories and recognized for its role in independently testing medications and identifying serious quality concerns that would otherwise go unnoticed.

We are proud to have worked with Bloomberg journalists Zachary Mider, Anna Edney, and Riley Griffin, whose reporting has been instrumental in driving awareness and accountability in pharmaceutical safety.

Highlighted Coverage Featuring Valisure:

• Indian-Made Cold Syrup Sent to Iraq Contains Poison, Test Shows (July 28, 2023)
• WHO Warns About Tainted Indian-Made Cold Medicine That’s Sold in Iraq (Aug. 7, 2023)
• The Pentagon Wants to Root Out Shoddy Drugs. The FDA Is In Its Way. (Dec. 4, 2023)
• US Military at Risk From Reliance on Cheap Foreign Drugs, Senators Say (March 19, 2024)

Key Stats:

• $50 billion – Estimated size of India’s pharmaceutical industry, the world’s largest producer of generics
• 900 – Number of drug recalls issued by the FDA in 2022, triple the number from four years prior

Valisure congratulates the Bloomberg team on this well-deserved honor and remains committed to advancing transparency and accountability in drug safety worldwide.

Read the full series via Bloomberg here.

‍